SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS
申请人:Bader Benjamin
公开号:US20120263708A1
公开(公告)日:2012-10-18
The present invention relates to substituted aminoquinoxaline compounds of general formula (I) in which (II), R
2
, R
3
, R
4
, R
6
, R
7
, n and m are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, as well as to intermediate compounds useful in the preparation of said compounds.
[EN] SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS<br/>[FR] AMINOQUINOXALINES SUBSTITUÉES SERVANT D'INHIBITEURS DE TYROSINE-THRÉONINE KINASES
申请人:BAYER SCHERING PHARMA AG
公开号:WO2011026579A1
公开(公告)日:2011-03-10
The present invention relates to substituted aminoquinoxaline compounds of general formula (I) in which (II), R2, R3, R4, R6, R7, n and m are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, as well as to intermediate compounds useful in the preparation of said compounds.